Table 1.
Comparison of laboratory parameters between positive and negative patients with COVID-19 on the first day of admission
| Variables | Positive(n = 26) | Negative(n = 74) | p value |
|---|---|---|---|
| WBC (× 109/L) | 10.95 ± 5.45 | 14.13 ± 7.26 | 0.02 |
| NEU (× 109/L) | 9.15 ± 5.67 | 12.09 ± 6.82 | 0.03 |
| LYM (× 109/L) | 1.4 ± 1.22 | 1.22 ± 0.8 | 0.48 |
| MONO (× 109/L) | 0.9 ± 1.99 | 0.76 ± 0.52 | 0.08 |
| EOS (× 109/L) | 0.04 ± 0.05 | 0.07 ± 0.11 | 0.23 |
| BASO (× 109/L) | 0.03 ± 0.04 | 1.25 ± 10.46 | 0.04 |
| NEU-R (%) | 78.72 ± 12.35 | 82.17 ± 11.94 | 0.14 |
| LYM-R (%) | 15.48 ± 12.78 | 10.21 ± 7.49 | 0.08 |
| MONO-R (%) | 5.52 ± 3.14 | 5.54 ± 3.7 | 0.54 |
| EOS-R (%) | 0.49 ± 0.72 | 0.64 ± 0.92 | 0.56 |
| BASO-R (%) | 0.23 ± 0.2 | 0.28 ± 0.39 | 0.40 |
| RBC (× 1012/L) | 4.6 ± 0.93 | 4.44 ± 0.75 | 0.39 |
| HGB (g/L) | 139.35 ± 23.82 | 143.03 ± 29.22 | 0.57 |
| HCT | 0.4 ± 0.06 | 0.4 ± 0.07 | 0.90 |
| PLT (× 109/L) | 198.23 ± 74.73 | 217.92 ± 116.57 | 0.60 |
| PT (s) | 13.49 ± 1.58 | 13.36 ± 1.33 | 0.70 |
| APTT (s) | 30.13 ± 4.1 | 30.47 ± 6.49 | 0.49 |
| TT (s) | 17.32 ± 1.56 | 17.19 ± 2.14 | 0.40 |
| ALT (U/L) | 106.86 ± 197.63 | 78.89 ± 129.13 | 0.88 |
| AST (U/L) | 120.58 ± 274.38 | 92.71 ± 155.94 | 0.42 |
| TBIL (μmol/L) | 21.89 ± 24.81 | 32.43 ± 58.49 | 0.33 |
| TC (mmol/L) | 6.84 ± 5.23 | 7.23 ± 5.07 | 0.28 |
| TG (mmol/L) | 6.63 ± 8.17 | 7.41 ± 7.7 | 0.32 |
| HDLC (mmol/L) | 1.3 ± 1.06 | 1.14 ± 0.7 | 0.47 |
| LDLC (mmol/L) | 2.78 ± 1.07 | 3.25 ± 1.45 | 0.18 |
| Crea (μmol/L) | 76.22 ± 46.92 | 73.5 ± 56.59 | 0.86 |
| GFR (mL/min) | 102.33 ± 33.25 | 103.62 ± 24.82 | 0.70 |
| AMY (U/L) | 608.53 ± 776.22 | 473.9 ± 682.32 | 0.60 |
| PAMY (U/L) | 510.77 ± 690.01 | 387.32 ± 579.75 | 0.65 |
| LPS (U/L) | 734.93 ± 880.1 | 706.84 ± 938.63 | 1.0 |
| K (mmol/L) | 3.96 ± 0.49 | 4.01 ± 0.64 | 0.90 |
| Na (mmol/L) | 138.77 ± 4.99 | 135.51 ± 6.33 | 0.03 |
| Cl (mmol/L) | 105.35 ± 6.34 | 103.46 ± 5.68 | 0.22 |
| Ca (mmol/L) | 2.33 ± 0.22 | 2.28 ± 0.25 | 0.41 |
| NT-proBNP (ng/L) | 557.1 ± 630.88 | 289.64 ± 462.1 | 0.06 |
| PCT (ng/mL) | 3.47 ± 9.53 | 1.38 ± 3.56 | 0.92 |
| IVGLU (mmol/L) | 9.2 ± 4.36 | 10.07 ± 6.35 | 0.70 |
| FBGLU (mmol/L) | 9.55 ± 3.66 | 11.02 ± 5.9 | 0.45 |
P value less than 0.05 is represented in bold
Summary statistics were presented as number (%) for categorical variables and as mean ± SD for continuous variables. A two-sided p value of less than 0.05 was considered statistically significant
WBC White blood cell, NEU neutrophil, LYM lymphocyte, MONO monocyte, EOS eosinophils, BASO basophils, NEU-R neutrophil rate, LYM-R lymphocyte rate, MONO-R monocyte rate, EOS-R eosinophil cell rate, BASO-R basophil cell rate, RBC red blood cell, HGB hemoglobin, HCT hematocrit, PLT platelet, PT prothrombin time, APTT activated partial thrombin time, TT thrombin time, ALT alanine aminotransferase, AST aspartate aminotransferase, TBIL total bilirubin, TC total cholesterol, TG triglyceride, HDLC high-density lipoprotein cholesterol, LDLC low-density lipoprotein cholesterol, Crea creatinine, GFR glomerular filtration rate, AMY amylase, PAMY pancreatic amylase, LPS lipase, NT-proBNP N-terminal pro brain natriuretic peptide, PCT procalcitonin, IVGLU intravenous glucose, FBGLU fingertip blood glucose